Cigna’s Evernorth invests $3.5B in ex-Walgreens specialty pharmacy

The investment gives Evernorth greater reach into specialty pharmacy services for providers, which Cigna’s COO has called an “important addressable market expansion opportunity.”

Scroll to Top